The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000713392p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
13/05/2026
Date registered
Help: Date registered
16/06/2026
Date last updated
Help: Date last updated
16/06/2026
Date data sharing statement initially provided
Help: Data sharing statement date
16/06/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Accuracy and precision of pre-operative planning (FORMUS LABS) and personalised surgical guides (OSSIS) in patients undergoing Primary Total Hip Replacement
Scientific title
The accuracy and precision of FORMUS LABS Pre-op Planning and OSSIS Patient Specific Instrumentation (PSI) for Primary Total Hip Replacement in Adults
Additional trial identifiers [1] 317280 0
IRA2025-31H
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Hip osteoarthritis 341908 0
Condition category
Condition code
Musculoskeletal 337966 337966 0 0
Osteoarthritis
Public Health 338122 338122 0 0
Health service research
Surgery 338123 338123 0 0
Other surgery

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
Primary total hip arthroplasty performed using FORMUS LABS pre-operative planning and OSSIS patient-specific instrumentation (PSI) guides and Zimmer Biomet implants combines standardised implants with individualised 3D planning and cutting guides. Both FORMUS LABS and OSSIS will be responsible for providing their standardised onboarding and training procedures as part of using their products, external to the study. This will be conducted prior to recruitment.

Pre-operatively, a CT-based 3D model of the patient's pelvis and femur is generated, with FORMUS LABS pre-operative planning software simulating ideal implant positioning for the patient. From this plan, a 3D-printed OSSIS PSI guide is produced, which mirrors the patient's bony anatomy. Intra-operatively, the operating surgeon can physically visualise the virtual plan, to assist them with executing planned implant positioning.

Post-operative assessments include CT imaging at approximately 6 weeks to assess accuracy to plan and patient-reported outcome measure (PROM) collection through to 12 months post-operatively.
Intervention code [1] 334055 0
Treatment: Surgery
Intervention code [2] 334056 0
Treatment: Devices
Description of the comparator or control
All THA cases included in this study will involve the use of the FORMUS LABS pre-op plan and OSSIS PSI, along with collection of implant utilisation records. The comparator will be implant utilisation records to satisfy the primary aim of the study.
Control group
Active

Outcomes
Primary outcome [1] 345397 0
Accuracy and precision of FORMUS LABS pre-op planning and OSSIS PSI templates will be assessed as a composite outcome.
Timepoint [1] 345397 0
Pre-operative plan , intra-operative execution, and post-operative (6 weeks) imaging
Secondary outcome [1] 461526 0
Intra-operative surgeon feedback on the OSSIS PSI useability. This will be assessed as a composite outcome.
Timepoint [1] 461526 0
Intra-operative
Secondary outcome [2] 461529 0
Restoration of leg length, offset, centre of rotation from post-op imaging compared to pre-operative plan. These will be assessed as a composite outcome.
Timepoint [2] 461529 0
Post-operative (6 weeks) vs pre-operative
Secondary outcome [3] 461530 0
Evaluate pain and physical function in THR patients. This will be assessed as a composite outcome.
Timepoint [3] 461530 0
Pre-operative, Post-operative 6wks, Post-operative 1yr
Secondary outcome [4] 461987 0
Hip joint awareness
Timepoint [4] 461987 0
Pre-operative, Post-operative 6wks, Post-operative 1yr
Secondary outcome [5] 461988 0
Quality of life
Timepoint [5] 461988 0
Pre-operative, Post-operative 6wks, Post-operative 1yr

Eligibility
Key inclusion criteria
Patients who are booked for primary total hip replacement to treat osteoarthritis at Fremantle Hospital
Minimum age
18 Years
Maximum age
80 Years
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• The individual is unable or unwilling to sign the Patient Informed Consent (PIC), specific to this study, and approved by the Institutional HREC.
• The individual is less than 18 or greater than 80 years of age.
• The individual is classified as morbidly obese (>40 BMI).
• The individual is physically or mentally compromised (i.e., currently being treated for a psychiatric disorder, senile dementia, Alzheimer’s disease, presence of alcohol or substance abuse), and is unwilling or unable to comply with postoperative scheduled clinical and radiographic evaluation and rehabilitation.
• The individual has a diagnosis other than primary osteoarthritis such as inflammatory arthritis, traumatic arthritis, avascular necrosis, slipped capital epiphysis, pelvic fracture, femoral fracture, failed fracture fixation or diastrophic variant.

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Who is / are masked / blinded?



Intervention assignment
Single group
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
WA
Recruitment hospital [1] 29522 0
Fremantle Hospital and Health Service - Fremantle
Recruitment postcode(s) [1] 45839 0
6160 - Fremantle

Funding & Sponsors
Funding source category [1] 321853 0
Commercial sector/Industry
Name [1] 321853 0
Zimmer Biomet Pty Ltd
Country [1] 321853 0
Australia
Primary sponsor type
Commercial sector/Industry
Name
Zimmer Biomet Pty Ltd
Address
Country
Australia
Secondary sponsor category [1] 324708 0
None
Name [1] 324708 0
Address [1] 324708 0
Country [1] 324708 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320392 0
WA Health Central HREC
Ethics committee address [1] 320392 0
Ethics committee country [1] 320392 0
Australia
Date submitted for ethics approval [1] 320392 0
19/03/2026
Approval date [1] 320392 0
Ethics approval number [1] 320392 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150330 0
A/Prof Christopher Jones
Address 150330 0
Orthopaedic Department, Level 6, Block B, Fremantle Hospital, 1 Alma St, Fremantle WA 6160
Country 150330 0
Australia
Phone 150330 0
+61 8 9431 2556
Fax 150330 0
Email 150330 0
Contact person for public queries
Name 150331 0
Simone Brockman
Address 150331 0
Department of Health (WA Health) PO Box 8172, Perth Business Centre, Perth, WA, 6849
Country 150331 0
Australia
Phone 150331 0
+61 409175930
Fax 150331 0
Email 150331 0
Contact person for scientific queries
Name 150332 0
Christopher Jones
Address 150332 0
Orthopaedic Department, Level 6, Block B, Fremantle Hospital, 1 Alma St, Fremantle WA 6160
Country 150332 0
Australia
Phone 150332 0
+61 8 9431 2556
Fax 150332 0
Email 150332 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.